A Study of Atezolizumab (Tecentriq®) in Ministry of Food and Drug Safety (MFDS)-Approved Indication(s)

Clinical trial NCT03232593 · COMPLETED

Trial details

NCT number: NCT03232593
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Study type: OBSERVATIONAL

Urothelial Carcinoma Carcinoma, Non-Small Cell Lung Small Cell Lung Carcinoma Triple Negative Breast Carcinoma Hepatocellular Carcinoma

Start date: 2017-11-29
Primary completion: 2022-08-12
Enrollment: 1758

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.